Clinical Trial Update: Pharmacodynamics Modeling to Optimize Dosage Regimens of Sulbactam in Patients With Acinetobacter Infections [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating pharmacodynamics modeling to optimize sulbactam dosage in patients with Acinetobacter infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acinetobacter Infections

Drugs mentioned

• Sulbactam (sulbactam)

Snippet

Sponsor: Sutep Jaruratanasirikul | Conditions: Acinetobacter Infections | Phase 4 | Status: COMPLETED